Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer

  1. Díaz-Gil, L.
  2. Brasó-Maristany, F.
  3. Locatelli, C.
  4. Centa, A.
  5. Győrffy, B.
  6. Ocaña, A.
  7. Prat, A.
  8. Pandiella, A.
Zeitschrift:
Journal of Experimental and Clinical Cancer Research

ISSN: 1756-9966

Datum der Publikation: 2021

Ausgabe: 40

Nummer: 1

Art: Artikel

DOI: 10.1186/S13046-021-02098-Z GOOGLE SCHOLAR lock_openOpen Access editor